Why Black Data Matters in Clinical Trial Research

Register Here

We are excited to be joined by Ricki Fairley, a CEO and co-founder of TOUCH, Black Breast Cancer Alliance, who is also a triple-negative (TNBC) survivor. Ricki will discuss the importance of the Black Data Matters (BDM) initiative established in June 2020. The main aim of this initiative is to bring attention to and focus on Black Breast Cancer patients, who have been shown to have a mortality rate over 40% higher than white breast cancer patients.

Ricki will share with us how she has led the BDM movement in Black communities nationwide to educate and enroll more Black women and breast cancer patients into clinical trials.